AUROBINDO PHARMA LTD.AUROBINDO PHARMA LTD.AUROBINDO PHARMA LTD.

AUROBINDO PHARMA LTD.

No trades
See on Supercharts
Market capitalization
‪636.97 B‬INR
‪19.28 B‬INR
‪246.38 B‬INR
‪281.54 M‬
Beta (1Y)
0.67

About AUROBINDO PHARMA LTD.

CEO
Kambam Nithyananda Reddy
Headquarters
Hyderabad
Employees (FY)
‪33.41 K‬
Founded
1986
ISIN
INE406A01037
FIGI
BBG000BMFT44
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AUROPHARMA is 1087.10 INR — it has decreased by 2.49% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange AUROBINDO PHARMA LTD. stocks are traded under the ticker AUROPHARMA.
AUROBINDO PHARMA LTD. is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA stock is 3.33% volatile and has beta coefficient of 0.67. Check out the list of the most volatile stocks — is AUROBINDO PHARMA LTD. there?
One year price forecast for AUROBINDO PHARMA LTD. has a max estimate of 1400.00 INR and a min estimate of 980.00 INR.
AUROPHARMA earnings for the last quarter are 12.83 INR per share, whereas the estimation was 11.03 INR resulting in a 16.30% surprise. The estimated earnings for the next quarter are 15.39 INR per share. See more details about AUROBINDO PHARMA LTD. earnings.
AUROBINDO PHARMA LTD. revenue for the last quarter amounts to ‪72.19 B‬ INR despite the estimated figure of ‪68.09 B‬ INR. In the next quarter revenue is expected to reach ‪73.75 B‬ INR.
Yes, you can track AUROBINDO PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
AUROPHARMA stock has fallen by 1.97% compared to the previous week, the month change is a 8.01% rise, over the last year AUROBINDO PHARMA LTD. has showed a 84.57% increase.
AUROPHARMA net income for the last quarter is ‪9.36 B‬ INR, while the quarter before that showed ‪7.57 B‬ INR of net income which accounts for 23.65% change. Track more AUROBINDO PHARMA LTD. financial stats to get the full picture.
Today AUROBINDO PHARMA LTD. has the market capitalization of ‪636.97 B‬, it has increased by 1.81% over the last week.
AUROBINDO PHARMA LTD. dividend yield was 0.58% in 2022, and payout ratio reached 9.12%. The year before the numbers were 1.35% and 19.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AUROBINDO PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
AUROPHARMA reached its all-time high on Jan 30, 2024 with the price of 1177.00 INR, and its all-time low was 40.15 INR and was reached on Nov 18, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has ‪33.41 K‬ employees. See our rating of the largest employees — is AUROBINDO PHARMA LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AUROBINDO PHARMA LTD. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AUROBINDO PHARMA LTD. stock shows the buy signal. See more of AUROBINDO PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AUROBINDO PHARMA LTD. future price: according to them, AUROPHARMA price has a max estimate of 1400.00 INR and a min estimate of 980.00 INR. Read a more detailed AUROBINDO PHARMA LTD. forecast: see what analysts think of AUROBINDO PHARMA LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AUROBINDO PHARMA LTD. EBITDA is ‪51.58 B‬ INR, and current EBITDA margin is 15.50%. See more stats in AUROBINDO PHARMA LTD. financial statements.